About conolidine
These benefits, along with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 support the principle of concentrating on ACKR3 as a novel approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders.A study review revealed in A